NO2236523T3 - - Google Patents

Info

Publication number
NO2236523T3
NO2236523T3 NO09004561A NO09004561A NO2236523T3 NO 2236523 T3 NO2236523 T3 NO 2236523T3 NO 09004561 A NO09004561 A NO 09004561A NO 09004561 A NO09004561 A NO 09004561A NO 2236523 T3 NO2236523 T3 NO 2236523T3
Authority
NO
Norway
Application number
NO09004561A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2236523T3 publication Critical patent/NO2236523T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
NO09004561A 2009-03-30 2009-03-30 NO2236523T3 (forum.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09004561.8A EP2236523B1 (en) 2009-03-30 2009-03-30 Method for producing cross-linked hyaluronic acid

Publications (1)

Publication Number Publication Date
NO2236523T3 true NO2236523T3 (forum.php) 2018-07-21

Family

ID=40908969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO09004561A NO2236523T3 (forum.php) 2009-03-30 2009-03-30

Country Status (6)

Country Link
EP (1) EP2236523B1 (forum.php)
DK (1) DK2236523T3 (forum.php)
ES (1) ES2662064T3 (forum.php)
NO (1) NO2236523T3 (forum.php)
PL (1) PL2236523T3 (forum.php)
PT (1) PT2236523T (forum.php)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20120071437A1 (en) * 2007-07-30 2012-03-22 Allergan, Inc. Tunable crosslinked polysaccharide compositions
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
MX2010005331A (es) 2007-11-16 2010-08-11 Vicept Therapeutics Inc Composiciones y metodos para tratamiento de purpura.
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9228027B2 (en) 2008-09-02 2016-01-05 Allergan Holdings France S.A.S. Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9371402B2 (en) 2009-04-09 2016-06-21 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP3520827B1 (en) 2010-03-22 2022-05-25 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
EP2703014A4 (en) * 2011-04-27 2014-12-17 Menicon Co Ltd SYNTHETIC ENAMEL MATERIAL
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CN103554528B (zh) * 2013-11-05 2016-05-11 北京化工大学 一种交联剂改性的透明质酸-聚天冬氨酸原位交联型水凝胶的制备方法
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
TWI716365B (zh) 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 注射型真皮填充劑組合物及其套組、製備方法、與使用
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
WO2016128550A1 (en) 2015-02-13 2016-08-18 Allergan Industrie, Sas Implants for sculpting, augmenting or correcting facial features such as the chin
WO2017016917A1 (en) * 2015-07-27 2017-02-02 Galderma Sa A process for efficient cross-linking of hyaluronic acid
EP3165233B1 (en) 2015-08-28 2021-08-18 Latvijas Universitate Biomaterial for treatment of acute and chronic skin wounds
WO2018187404A1 (en) 2017-04-05 2018-10-11 Gelesis, Llc Improved superabsorbent materials and methods of production thereof
RU2659175C1 (ru) * 2017-04-12 2018-06-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Композиция на основе бактериальной целлюлозы и гиалуроновой кислоты
FR3095206B1 (fr) * 2019-04-17 2021-11-05 Lab Vivacy Procede de reticulation d’un polymere
CN111234271B (zh) * 2019-08-29 2021-10-01 上海其胜生物制剂有限公司 一种引导交联透明质酸钠凝胶结构重排的方法
EP4482581A4 (en) * 2022-02-23 2025-07-30 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Hyaluronic acid hydrogel formulation with phytoestrogen for the treatment of vaginal atrophy and vaginal rejuvenation and manufacturing process therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
DE69822285T2 (de) * 1998-02-27 2005-01-27 Stichting Hyppomedics Verfahren zur Herstellung von vernetzter Hyaluronsäure
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JP2007500027A (ja) * 2003-07-30 2007-01-11 アンタイス エス．エイ． 生物医学的な使用のための複合マトリックス
EP1750769B1 (en) 2004-05-20 2013-01-23 Mentor Worldwide LLC Methods for making injectable polymer hydrogels
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法

Also Published As

Publication number Publication date
PL2236523T3 (pl) 2018-07-31
DK2236523T3 (en) 2018-05-07
EP2236523B1 (en) 2018-02-21
PT2236523T (pt) 2018-03-21
ES2662064T3 (es) 2018-04-05
EP2236523A1 (en) 2010-10-06

Similar Documents

Publication Publication Date Title
BRPI0925311A2 (forum.php)
BR112012008195A2 (forum.php)
BR112012003062A2 (forum.php)
BR112012008267A2 (forum.php)
BR112012012396A2 (forum.php)
BR112012000607A2 (forum.php)
BR122021004633A2 (forum.php)
BR112012003080A2 (forum.php)
BR112012000665A2 (forum.php)
BR112012012487A2 (forum.php)
BR122017024704A2 (forum.php)
BR112012003853A2 (forum.php)
NO2236523T3 (forum.php)
BR112012009797A2 (forum.php)
BR112012012080A2 (forum.php)
BR112012009446A2 (forum.php)
BRPI1005795A2 (forum.php)
BR112012010357A2 (forum.php)
BR112012007656A2 (forum.php)
BR112012001263A2 (forum.php)
BR122019005883A2 (forum.php)
BR112012000159A2 (forum.php)
BRPI1004942A2 (forum.php)
BR112012014856A2 (forum.php)
BR112012002627A2 (forum.php)